Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump’s Supreme Court nominee could face questions on healthcare record

Brett Kavanaugh, President Donald Trump’s pick to replace Supreme Court Justice Anthony Kennedy and a D.C. Appeals Court judge, will likely face questions on his healthcare record during confirmation hearings.

Thumbnail

CMS will allow participants to withdraw from new bundles in March 2019

CMS has announced participants in the Bundled Payment for Care Improvement (BPCI) Advanced model will be able to retroactively withdraw beginning in March 2019.

Trump attacks Pfizer after drug price increase

President Donald Trump lashed out at drug manufacturer Pfizer after the company raised prices for 100 drugs by an average of 9 percent, effective July 1.

Thumbnail

Arizona law intended to limit opioid prescriptions may hurt chronic pain patients

States are desperate to act in the national opioid epidemic, but laws limiting opioid prescriptions and doses are negatively impacting chronic pain patients and leaving doctors conflicted about care delivery, NPR reported.

Thumbnail

Trump administration halts ACA risk adjustment payments, potentially upending insurance markets

On July 7, CMS announced it will stop making risk adjustment payments, which were designed as part of the Affordable Care Act (ACA) to help insurers that accept more high-cost patients avoid major losses.

Thumbnail

CMS delays deadline for opting into bundled-payment initiative

CMS bumped back the due date for providers to opt into the Bundled Payments for Care Improvement (BPCI) Advanced model—moving the final date to Aug. 8 from Aug. 1. The move comes in amid growing concerns from those in the industry that claims data were not provided in a timely fashion.

CMS approves Oklahoma proposal for value-based Medicaid agreements with drug manufacturers

CMS has issued an approval to Oklahoma to negotiate value-based supplemental rebate agreements directly with drug manufacturers, which could produce extra rebates for state, should clinical outcomes not be achieved.

Thumbnail

CMS policy to reduce hospital-acquired infections has minimal impact on reimbursement

New research published in Infection Control & Hospital Epidemiology suggests the 2008 CMS’ policy, Hospital Inpatient Prospective Payment System (IPPS), which penalizes hospitals for hospital-associated conditions (HAC) present at the time of the patients’ admission to the hospital has had a minimal impact on hospital reimbursement.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”